Fibrin sealant (Evicel® [quixil®/crosseal™]): A review of its use as supportive treatment for haemostasis in surgery

Drugs

Volumn 71, Issue 14, 2011, Pages 1893-1915

  Dhillon, Sohita ^a   De Boer, M T ^b   Papacharalabous, E N ^c   Schwartz, M ^d  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOGLUE; CALCIUM ALGINATE; COSEAL; CROSSEAL; CRYOSEAL; CYANOACRYLATE; DERMABOND; ENBUCRILATE; FIBRIN GLUE; FIBRINOGEN; GLUBRAN; OXIDIZED REGENERATED CELLULOSE; QUIXIL; THROMBIN; TRANEXAMIC ACID; UNCLASSIFIED DRUG; WARFARIN;

ABDOMINAL ABSCESS; ABDOMINAL SURGERY; ADENOIDECTOMY; AIR EMBOLISM; ANAPHYLAXIS; BLEEDING; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONSTIPATION; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG TOLERABILITY; FEVER; FIBRIN CLOT; GRAFT OCCLUSION; HEMATOMA; HEMOSTASIS; HUMAN; HYPOKALEMIA; INSOMNIA; LIVER RESECTION; LIVER SURGERY; LUNG EMBOLISM; METHODOLOGY; NAUSEA; NONHUMAN; NOSE SURGERY; ORTHOPEDIC SURGERY; PAIN; PERIPHERAL EDEMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; THROAT SURGERY; THROMBOSIS; TONSILLECTOMY; TOTAL KNEE REPLACEMENT; VASCULAR SURGERY;

ANIMALS; BLOOD LOSS, SURGICAL; CLINICAL TRIALS AS TOPIC; FIBRIN TISSUE ADHESIVE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS;

BOVINAE;

EID: 80053183512     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11207700-000000000-00000     Document Type: Review

References (56)

1. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion (Paris) 2008; 48 (7): 1502-16
2. Seyednejad H, Imani M, Jamieson T, et al. Topical haemostatic agents. Br J Surg 2008; 95 (10): 1197-225
3. Tredree R, Beierlan W, Debrix I, et al. Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists. EJHP-S 2006; 12 (1): 3-9
4. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001 Aug; 182 (2 Suppl.): 1S-7S (Pubitemid 32898601)
5. Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251 (2): 217-28
6. EuropeanMedicinesAgency. Assessment report for Eviceĺ[online]. Available from URL: http://www.ema.europa.eu/docs/en-GB/documenťlibrary/ EPAR/Public-assessmenťreport/human/000898/WC500030826.pdf [Accessed 2011 May 24]
7. Cox S, Cole M, Mankarious S, et al. Effect of tranexamic acid incorporated in fibrin sealant clots on the cell behavior of neuronal and nonneuronal cells. J Neurosci Res 2003 Jun 15; 72 (6): 734-46 (Pubitemid 36666267)
8. European Medicines Agency. Quixiĺ: summary of product characteristics [online]. Available from URL: http://www. ethicon360emea.com/ sites/default/files/products/QUIXIL% 20SmPC%2017.8.10.pdf [Accessed 2011 Jun 13]
9. Ethicon Inc. Eviceĺfibrin sealant (human) approved for general hemostasis in surgery [media release]. 2008 Jan 10 [online]. Available from URL http://www.reuters.com/ar ticle/2008/01/10/idUS229417+10-Jan-2008+PRN20080110
10. Omrix biopharmaceutical. Commercial biosurgical products [online]. Available from URL: http://www.omrix.com/products/bio-commercial.asp [Accessed 2011 Jun 27]
11. Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg 2007; 24 (4): 288-93 (Pubitemid 47174045)
12. Adams RL, Bird RJ. Review article: coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton) 2009 Aug; 14 (5): 462-70
13. Dickneite G, Metzner H, Pfeifer T, et al. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003; 112 (1-2): 73-82 (Pubitemid 38167589)
14. Hickerson WL, Nur I, Meidler R. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants. Blood Coagul Fibrinolysis 2011 Jan; 22 (1): 19-23
15. Lamsa T, Jin HT, Sand J, et al. Tissue adhesives and the pancreas: biocompatibility and adhesive properties of 6 preparations. Pancreas 2008 Apr; 36 (3): 261-6 (Pubitemid 351440930)
16. Azadani AN, Matthews PB, Ge L, et al. Mechanical properties of surgical glues used in aortic root replacement. Ann Thorac Surg 2009 Apr; 87 (4): 1154-60
17. Nur I, Lyahovetsky Y, Bar L, et al. Commercial fibrin sealants are not equivalent in a rabbit liver-resection model which quantitatively evaluates hemostasis and formation of adhesions. Eur Surg Res 2005 May 30; 37 (3): 159-65 (Pubitemid 41160148)
18. Ornelas L, Padilla L, Di Silvio M, et al. Fibrin glue: an alternative technique for nerve coaptation: part I. Wave amplitude, conduction velocity, and plantar-length factors. J Reconstr Microsurg 2006 Feb; 22 (2): 119-22 (Pubitemid 43269914)
19. Bivalacqua TJ, Guzzo TJ, Schaeffer EM, et al. Application of Evicel to cavernous nerves of the rat does not influence erectile function in vivo. Urology 2008 Nov; 72 (5): 1169-73
20. European Medicines Agency. Eviceĺsolution for sealant: summary of product characteristics [online]. Available from URL: http://www.ema.europa.eu/ docs/en-GB/docu menťlibrary/EPAR/ProducťInformation/human/0008 98/WC500030828.pdf [Accessed 2011 Jun 9]
21. Ethicon Inc. Eviceĺfibrin sealant (human): US prescribing information [online]. Available from URL: http://www.fda. gov/downloads/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/ FractionatedPlasmaProducts/UCM114073.pdf [Accessed 2011 Jun 10]
22. Nur I, Routledge L, Lushkov G, et al. Absorption and elimination of alpha-thrombin and tranexamic acid after fibrin sealant application on resected livers in rabbits. Blood Coagul Fibrinolysis 1998 Sep; 9 (6): 533-7 (Pubitemid 28508795)
23. Chalmers RTA, Darling III RC, Wingard JT, et al. Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures. Br J Surg 2010 Dec; 97 (12): 1784-9; discussion 1790
24. Sintler MP, Mahmood A, Smith SRG, et al. Randomized trial comparing Quixil surgical sealant with Kaltostat hemostatic dressing to control suture line bleeding after carotid endarterectomy with ePTFE patch reconstruction. World J Surg 2005 Oct; 29 (10): 1259-62 (Pubitemid 41625969)
25. Schwartz M, Madariaga J, Hirose R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004 Nov; 139 (11): 1148-54 (Pubitemid 39463445)
26. Fischer CP, Wood CG, Shen J, et al. A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat. Clin Appl Thromb Hemost. Epub 2011 Aug 25
27. Papacharalabous EN, Giannopoulos T, Tailor A, et al. Intraoperative haemostasis with new fibrin surgical sealant (Quixiĺ) in gynaecological oncology. J Obstet Gynaecol 2009 Apr; 29 (3): 233-6
28. Crawford RW, Giangrande P, Murray D. Fibrin sealant reduces blood loss in total hip arthroplasty. Hip Int 1999; 9 (3): 127-32 (Pubitemid 29476012)
29. Levy O, Martinowitz U, Oran A, et al. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty: a prospective, randomized, multicenter study. J Bone Joint Surg Am 1999 Nov; 81 (11): 1580-8
30. Majoras N, Fabi D, Patel P, et al. Use of novel fibrin sealant in total hip and knee arthroplasty [poster no. 16]. 28th Annual Meeting of the Mid-America Orthopaedic Association; 2010 Apr 21-24; Lost Pines (TX)
31. Molloy DO, Archbold HAP, Ogonda L, et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Jt Surg Ser B 2007; 89 (3): 306-9 (Pubitemid 46563903)
32. Wang GJ, Hungerford DS, Savory CG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001 Oct; 83-A (10): 1503-5 (Pubitemid 32953347)
33. Wang GJ, Goldthwaite Jr CA, Burks S, et al. Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long-Term Eff Med Implants 2003; 13 (5): 399-411 (Pubitemid 37329082)
34. Vaiman M, Eviatar E, Segal S. The use of fibrin glue as hemostatic in endonasal operations: a prospective, randomized study. Rhinology 2002 Dec; 40 (4): 185-8 (Pubitemid 36040520)
35. Vaiman M, Eviatar E, Segal S. Effectiveness of secondgeneration fibrin glue in endonasal operations. Otolaryngol Head Neck Surg 2002 Apr; 126 (4): 388-91 (Pubitemid 41123560)
36. Vaiman M, Eviatar E, Shlamkovich N, et al. Effect of modern fibrin glue on bleeding after tonsillectomy and adenoidectomy. Ann Otol Rhinol Laryngol 2003 May; 112 (5): 410-4 (Pubitemid 36617552)
37. Baugh RF, Archer SM, Mitchell RB, et al. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 2011 Jan; 144 Suppl. 1: S1-30
38. Vaiman M, Sarfaty S, Shlamkovich N, et al. Fibrin sealant: alternative to nasal packing in endonasal operations. A prospective randomized study. Isr Med Assoc J 2005 Sep; 7 (9): 571-4 (Pubitemid 41309224)
39. Vaiman M, Eviatar E, Shlamkovich N, et al. Use of fibrin glue as a hemostatic in endoscopic sinus surgery. Ann Otol Rhinol Laryngol 2005 Mar; 114 (3): 237-41 (Pubitemid 40381542)
40. Vaiman M, Sarfaty S, Eviatar E. The use of fibrin sealant as a glue for septoplasty and conchotomy. Rhinology 2009 Sep; 47 (3): 297-300
41. Center for Biologics Evaluation and Research. 1-year postapproval adverse event review [online]. Available from URL: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM192059.pdf [Accessed 2011 Aug 10]
42. Horowitz B, Busch M. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion (Paris) 2008 Aug; 48 (8): 1739-53
43. Baxter Healthcare Corporation. Tisseeĺ(fibrin sealant): US prescribing information [online]. Available from URL: http://www.fda.gov/ downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProducts BLAs/FractionatedPlasmaProducts/UCM072968.pdf [Accessed 2011 Jun 24]
44. CSL Behring. BeriplasťP combi set (powders and solvents for sealants): company core datasheet [online]. Available from URL: http://www.cslsurgery.com/international/ber iplast/product/full.html [Accessed 2011 Jun 24]
45. Schlag MG, Hopf R, Redl H. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model. Neurosurgery 2000 Dec; 47 (6): 1463-7
46. Furtmuller R, Schlag MG, Berger M, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a g-aminobutyric acidA receptor antagonistic effect. J Pharmacol Exp Ther 2002 Apr; 301 (1): 168-73 (Pubitemid 34256345)
47. Levy JH. Efficacy and safety of aprotinin in cardiac surgery. Orthopedics 2004 Jun; 27 (6 Suppl.): s659-62 (Pubitemid 38923420)
48. Bar L,Malka O, Naboichenko E, et al. The binding of fibrin sealant to collagen is influenced by the method of purification and the cross-linked fibrinogen-fibronectin (heteronectin) content of the 'fibrinogen' component. Blood Coagul Fibrinolysis 2005 Mar; 16 (2): 111-7 (Pubitemid 40418589)
49. Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2003; (2): CD004171
50. Lee S, Pham AM, Pryor SG, et al. Efficacy of crosseal fibrin sealant (human) in rhytidectomy. Arch Facial Plast Surg 2009 Jan 28; 11 (1): 29-33
51. Pryor SG, Sykes J, Tollefson TT. Efficacy of fibrin sealant (human) (Evicel) in rhinoplasty: a prospective, randomized, single-blind trial of the use of fibrin sealant in lateral osteotomy. Arch Facial Plast Surg 2008 Sep-Oct; 10 (5): 339-44
52. Tempesta BJ, Gharagozloo F, Schwartz A, et al. Aerostasis with human fibrin sealant (Evicel) in patients undergoing pulmonary resection [abstract]. Chest 2007; 132 (4 Suppl.): 661S
53. Vaiman M, Segal S, Eviatar E. Fibrin glue treatment for epistaxis. Rhinology 2002 Jun; 40 (2): 88-91 (Pubitemid 34624907)
54. Vaiman M, Martinovich U, Eviatar E, et al. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Blood Coagul Fibrinolysis 2004 Jun; 15 (4): 359-63 (Pubitemid 38757066)
55. Bahar I, Weinberger D, Dan G, et al. Pterygium surgery: fibrin glue versus vicryl sutures for conjunctival closure. Cornea 2006 Dec; 25 (10): 1168-72 (Pubitemid 46005854)
56. Steuten L, Vallejo-Torres L, Bastide P, et al. Analysing uncertainty around costs of innovative medical technologies: the case of fibrin sealant (Quixiĺ) for total knee replacement. Health Policy 2009 Jan; 89 (1): 46-57